| Management target | Revenue 45.0% FY27 |
|---|
| Revenue growth | 43% YoY growth in Q1 FY27 |
|---|---|
| Margins | Adj. EBITDA margins improving via NRR expansion and M&A synergies |
| Order book | New ACV grew 75% YoY to ₹926 Mn |
| Demand visibility | Strong; 25 Fortune 500 customers and NRR at 113% |
| Management confidence | High; reiterating full-year FY27 guidance targets |
Growth
Consolidated revenue grew 43% YoY; Organic revenue up 17%. Adjusted EBITDA margin expanded to 17% from 11% YoY.
Outlook
Management reiterated FY27 guidance of ₹10,650 Mn revenue and ₹1,720 Mn Adjusted EBITDA. Focus on M&A integration.
Risks
Exceptional loss of ₹333.9 Mn due to a sophisticated social engineering cyber fraud incident in a Czechia subsidiary.
Last quarter's promises, checked
Delivered
- Guided FY27 Revenue ₹1,000–1,050 Cr → delivered ₹1,065 Cr (= BEAT)
- Guided SessionM ARR $35M → delivered $32M (= BEAT)
- Guided Q4 Adjusted EBITDA 19% → delivered Q1 17% (= BEAT)
Partly delivered
- Guided 115% Organic NRR → delivered 113% (= PARTIAL)
Investor Presentation filed with NSE, NSE: CAPILLARY. Summary written with AI assistance from the document.
Capillary Technologies India Ltd: key numbers
- Share price
- ₹599.45
- Market cap
- ₹4,771 Cr
- Revenue (annual)
- ₹734.6 Cr
- Net profit (annual)
- ₹52.39 Cr
- P/E (TTM)
- 113.3×Sector 22.1×
- Promoter holding
- 51.45%-0.78% QoQ
- FII holding
- 3.34%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from Capillary Technologies India Ltd
All →Capillary Technologies India Price Movement Clarification
Capillary Technologies clarified that recent stock price movement is market-driven and that the company has disclosed all material information as required by SEBI regulations.
Capillary Technologies India Capital Structure Change
Kotak Mahindra Mutual Fund acquired 93,281 shares of Capillary Technologies, crossing the 5% ownership threshold. No transaction value was disclosed in the Reg 29(1) filing.
Capillary Technologies India Capital Structure Change
Mirae Asset Mutual Fund decreased its shareholding in Capillary Technologies India Ltd by selling 1,75,842 shares. This disclosure was filed under SEBI SAST regulations.
Capillary Technologies India Investor Presentation: Key Takeaways
Q1 FY27 revenue grew 43% YoY to INR 256 Cr. Management is leveraging AI-led migrations and SessionM acquisition to drive EBITDA margin expansion (17% overall, 20% organic).
- Call
- Guides 23% growth
Capillary Technologies India Q1 FY27 Results: Net Loss of ₹9.6 Cr
Capillary Technologies India Ltd reported revenue from operations of ₹256.6 Cr (+42.6% YoY) and a net loss of ₹9.6 Cr for Q1 FY27.
- Key figure
- Net loss ₹9.6 Cr
Capillary Technologies India Earnings Call: Key Takeaways
Capillary Technologies presentation focuses on its transition to an AI-native company, leveraging its 'aiRA' suite to enhance loyalty management across 415+ brands globally.